Kevin Fitzgerald - Oct 6, 2021 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Kevin Joseph Fitzgerald by PoA
Stock symbol
OVID
Transactions as of
Oct 6, 2021
Transactions value $
$0
Form type
4
Date filed
10/7/2021, 04:44 PM
Next filing
Feb 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (Right to Buy) Award $0 +30K $0.00 30K Oct 6, 2021 Common Stock 30K $3.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest as follows: 1/36th of the shares subject to the option shall vest every month after October 6, 2021 such that the option will have vested in full on October 6, 2024, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan) on each vesting date.